BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
Switch Symbol:
Revenue Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$450.71M
↑ 223% above average
Average (9y)
$139.72M
Historical baseline
Range
High:$450.71M
Low:$17.81M
CAGR
+28.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $450.71M | +36.0% |
| 2023 | $331.41M | +22.4% |
| 2022 | $270.83M | +72.3% |
| 2021 | $157.17M | +782.4% |
| 2020 | $17.81M | -63.5% |
| 2019 | $48.84M | +136.5% |
| 2018 | $20.65M | -18.0% |
| 2017 | $25.19M | -4.4% |
| 2016 | $26.35M | -45.4% |
| 2015 | $48.26M | - |